Immunohistochemical study of prostacyclin-stimulating factor (PSF) in the diabetic and atherosclerotic human coronary artery

Diabetes

Volumn 46, Issue 10, 1997, Pages 1627-1632

  Sekiguchi, Naotaka ^a,b   Umeda, Fumio ^a   Masakado, Mitsunori ^a   Ono, Yasuhiro ^a   Hashimoto, Toshihiko ^a   Nawata, Hajime ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b NONE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN C; VASCULOTROPIN;

ARTICLE; CELL CULTURE; CELL PROLIFERATION; DIABETIC RETINOPATHY; GENE EXPRESSION; HUMAN; HUMAN CELL; NEOVASCULARIZATION (PATHOLOGY); PIGMENT EPITHELIUM; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER;

EID: 0030873952     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.46.10.1627     Document Type: Article

References (39)

1. Moncada S, Gryglewski RJ, Bunting S, Vane JR: An enzyme isolated from arterials transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature 263:663-665, 1976
2. Moncada S: Biological importance of prostacyclin. Br J Pharmac 76:3-31, 1982
3. Colwell JA, Winocour PD, Halushka V: Do platelets have anything to do with diabetic microvascular disease? Diabetes 32 (Suppl. 2):14-19, 1983
4. Inoguchi T, Umeda F, Watanabe J, Ibayashi H: Stimulatory activity on prostacyclin production decreases in sera from streptozotocin-induced diabetic rats. Diabetes Res Clin Pract 3:243-248, 1987
5. Larrue J, Rigaud M, Daret D, Demond J, Durand J, Bricaud H: Prostacyclin production by cultured smooth muscle cells from atherosclerotic rabbit aorta. Nature 285:480-482, 1980
6. MacIntyre DE, Pearson JD, Gordon JL: Localization and stimulation of prostacyclin production in vascular cells. Nature 271:549-551, 1978
7. Inoguchi T, Umeda F, Watanabe J, Ibayashi H: Reduced serum-stimulatory activity on prostacyclin production by cultured aortic endothelial cells in diabetes mellitus. Haemostasis 16:447-452, 1986
8. Inoguchi T, Umeda F, Ono H, Kunisaki M, Watanabe J, Nawata H: Abnormality in prostacyclin-stimulatory activity in sera from diabetics. Metabolism 38:837-842, 1989
9. Umeda F, Yamauchi T, Inoguchi T, Nawata H: Partial purification of serum prostacyclin stimulatory activity by heparin-agarose column: abnormality detected in diabetics. Diabetes Res Clin Pract 16:109-115, 1992
10. Yamauchi T, Umeda F, Masakado M, Ono Y, Nawata H: Serum-free conditioned medium of human diploid fibroblast cells contains an activity that stimulates prostacyclin production by cultured bovine aortic endothelial cells. Biochem Mol Biol Int 31:65-71, 1993
11. Yamauchi T, Umeda F, Masakado M, Isaji M, Mizushima S, Nawata H: Purification and molecular cloning of prostacyclin-stimulating factor from serumfree conditioned medium of human diploid fibroblast cells. Biochem J 303:591-598, 1994
12. Ono Y, Hashimoto T, Umeda F, Masakado M, Yamauchi T, Mizushima S, Isaji M, Nawata H: Expression of prostacyclin-stimulating factor, a novel protein, in tissues of Wistar rats and in cultured cells. Biochem Biophys Res Commun 202:1490-1496, 1994
13. Masakado M, Umeda F, Takei A, Hashimoto T, Sueishi K, Nawata H: Immunohistochemical localization of a novel peptide, prostacyclin-stimulating factor (PSF), in human tissues. Thromb Haemost 74:1407-1410, 1995
14. Ross R: Growth of smooth muscle in culture and formation of elastic fibers. J Cell Biol 50:172-186, 1971
15. Sakakibara F, Hotta N, Koh N, Sakamoto N: Effects of high glucose concentrations and epalrestat on sorbitol and myo-inositol metabolism in cultured rabbit aortic smooth muscle cells. Diabetes 42:1594-1600, 1993
16. Guesdon JL, Ternynck T, Averameas S: The use of avidin-biotin interaction in immunoenzymatic techniques. J Histochem Cytochem 27:1131-1139, 1979
17. Westermark P, Wilander E, Westermark GT, Johnson KH: Islet amyloid polypeptide-like immunoreactivity in the islet B cells of type 2 (non-insulindependent) diabetic and non-diabetic individuals. Diabetologia 30:887-892, 1987
18. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159, 1987
19. Furchgott RF, Zawadzki JV: The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288:373-376, 1980
20. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T: A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 323:411-415, 1988
21. Johnson M, Harrison HE, Raftery AT, Elder JB: Vascular prostacyclin may be reduced in diabetes in man. Lancet i:325-326, 1979
22. Karpen CW, Pritchard KA, Merola JAJ, Panganamala RV: Alterations of the prostacyclin-thromboxane ratio in streptozotocin induced diabetic rats. Prostaglandins Leukotrienes Med 8:93-103, 1982
23. Udvardy M, Torok I, Rak K: Plasma thromboxane and prostacyclin metabolite ratio in atherosclerosis and diabetes mellitus. Thromb Res 47:479-484, 1987
24. Ziboh VA, Maruta H, Lord J, Cagle WD, Lucky W: Increased biosynthesis of thromboxane A2 by diabetic platelets. Eur J Clin Invest 9:223-228, 1979
25. Aanderud S, Krane H, Nordy A: Influence of glucose, insulin and sera from diabetic patients on the prostacyclin synthesis in vitro in cultured human endothelial cells. Diabetologia 28:641-644, 1985
26. Umeda F, Inoguchi T, Nawata H: Reduced stimulatory activity on prostacyclin production by cultured endothelial cells in serum from aged and diabetic patients. Atherosclerosis 75:61-66, 1989
27. Inoguchi T, Umeda F, Kunisaki M, Ishii H, Yamauchi T, Nawata H: Platelet stimulation for prostacyclin production in aortic endothelial cell cultures: alteration in diabetes mellitus. Horm Metab Res 23:539-544, 1991
28. Dembinska-Kiec A, Gryglewska T, Zmuda A, Gryglewski RJ: The generation of prostacyclin by arteries and by the coronary vascular bed is reduced in experimental atherosclerosis in rabbits. Prostaglandins 14:1025-1034, 1977
29. Sinzinger H, Feigl W, Silberbauer K: Prostacyclin generation in atherosclerotic arteries. Lancet ii:469, 1979
30. Willis AL, Snith DL, Vigo C, Kluge AF: Effects of prostacyclin and orally active stable mimetic agent RS-93427-007 on basic mechanisms of atherogenesis. Lancet ii:682-683, 1986
31. Hajjar DP, Weksler BB, Falcone DJ, Hefton JM, Tack-Goldman K, Minick CR: Prostacyclin modulates cholesteryl ester hydrolytic activity by its effect on cyclic adenosine monophosphate in rabbit aortic smooth muscle cells. J Clin Invest 70:479-488, 1982
32. Orekhov AN, Tertov VV, Smirnov VN: Prostacyclin analogues as antiatherosclerotic drugs. Lancet ii:521, 1983
33. Libby P, Warner SJC, Friedman GB: Interleukin 1: a mitogen for human vascular smooth muscle cells that induces the release of growth-inhibitory prostanoids. J Clin Invest 81:487-498, 1988
34. Rossi V, Breviario F, Ghezzi P, Dejana E, Mantovani A: Prostacyclin synthesis induced in vascular cells by interleukin-1. Science 229:174-176, 1985
35. Kawakami M, Ishibashi S, Ogawa H, Murase T, Takaku F, Shibata S: Cachectin/TNF as well as interleukin-1 induces prostacyclin synthesis in cultured vascular endothelial cells. Biochem Biophys Res Commun 141:482-487, 1986
36. Coughlin SR, Moskowitz MA, Zetter BR, Antoniades HN, Levine L: Plateletdependent stimulation of prostacyclin synthesis by platelet-derived growth factor. Nature 288:600-602, 1980
37. Ristimaki A, Ylikorkala O, Perheentupa J, Viinikka L: Epidermal growth factor stimulates prostacyclin production by cultured human vascular endothelial cells. Thromb Haemostasis 59:248-250, 1988
38. Ristimaki A: Transforming growth factor alpha stimulates prostacyclin production by cultured human vascular endothelial cells more potently than epidermal growth factor. Biochem Biophys Res Commun 160:1100-1105, 1989
39. Williamson JR, Chang K, Frangos M, Hasan KS, Ido Y, Kawamura T, Nyengaard JR, van den Enden M, Kilo C, Tilton RG: Hyperglycemic pseudohypoxia and diabetic complications. Diabetes 42:801-813, 1993